Page 184 - FINAL PROGRAM

P-710 The effect of elevated late follicular phase serum progesterone on IVF outcome in good prognosis patients
A. Osman (United Kingdom)
P-711 High level of androgen during controlled ovarian stimulation cycle impairs endometrium receptivity in PCOS patients
d. Wu (China)
P-712 Extensive analysis de nes actual differences in absolute and “per-follicle” Anti-Müllerian hormone (AMH) levels obtained by manual and new automated assays
T. Tadros (France)
P-713 Hormonal parameters before and after withdrawal using vaginal micronized progesterone in anovulatory patients with polycystic ovary syndrome
B. Alvaro Mercadal (Spain)
P-714 Improved human oocyte in vitro maturation in co-culture with cumulus cells from mature oocytes in the same patient: a prospective study
I. Virant - Klun (Slovenia)
P-715 A single dose new long-acting GnRH-antagonist Degarelix effectively downregulates LH in stimulated IVF cycles triggered with agonist for oocyte maturation. A proof of concept study E. Papanikolaou (Greece)
P-716 Role of Karyotyping and FMR gene screening in the anticipation of diagnosis of Premature Ovarian Insuf ciency (POI)
M.L. Shenoy (India)
P-717 Metformin decreases bone turnover in polycystic ovary syndrome
S. Lingaiah (Finland)
P-718 Mild versus conventional ovarian stimulation for poor responders undergoing IVF / ICSI: a prospective randomized study
C. Siristatidis (Greece)
P-719 Anti-Müllerian Hormone (AMH) affects Forkhead box L2 (FOXL2) expression: possible implications in early phases of folliculogenesis
S. Sacchi (Italy)
P-720 Luteal phase ovarian stimulation produces competent oocytes in women with diminished ovarian reserve
Z. Liu (U.S.A.)
P-721 Is there a bridge between diminished ovarian reserve and in ammation? A pilot study
A. Bourdiec (Canada)
P-722 High AMH doesn’t guarantee high pregnancy rate in old patients: AMH should be interpreted with age for outcome prediction of IUI or IVF
Y. Ku (Korea, South)
180